Systemic side effects of topical beta-adrenergic blockers (Q41169778)

27 September 2017

1 reference

title

Systemic side effects of topical beta-adrenergic blockers (English)

1 reference

27 September 2017

Stewart WC

1

1 reference

27 September 2017

Castelli WP

series ordinal

2

1 reference

27 September 2017

publication date

1 September 1996

1 reference

27 September 2017

1 reference

27 September 2017

volume

19

1 reference

27 September 2017

issue

9

1 reference

27 September 2017

page(s)

691-697

1 reference

Timolol maleate: efficacy and safety

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

A dose-ranging study to evaluate the beta-adrenoceptor selectivity of single doses of betaxolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

Congestive heart failure from betaxolol. Case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

Beta-blockers: use for arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

Antihypertensive drugs and lipid profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

Topical timolol decreases plasma high-density lipoprotein cholesterol level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

Adverse reactions from timolol administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

Topical beta-blocker therapy and central nervous system side effects. A preliminary study comparing betaxolol and timolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2FCLC.4960190904

21 January 2018

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

A sensitive radioligand binding assay for timolol in plasma

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

The paradox of beta-adrenergic blockade for the management of congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Side effects of timolol

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Beta 1- and beta 2-antagonist activity of topically applied betaxolol and timolol in the systemic circulation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Ocular Beta-Blockers and Systemic Effects

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Beta blockers in heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Beta blockade in congestive heart failure--the need for a definitive study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Systemic adverse reactions to glaucoma medications

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Early postmarketing surveillance of betaxolol hydrochloride, September 1985-September 1986

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Choosing the right beta-blocker. A guide to selection

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Coronary risk prediction in adults (the Framingham Heart Study)

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Recent studies on the effects of beta blockers on blood lipid levels

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

The Relevance of Intrinsic Sympathomimetic Activity for β-Blocker-Induced Changes in Plasma Lipids

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Topical timolol and serum lipoproteins

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Exercise performance and beta-blockade

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Haemodynamic effects of beta-adrenergic blockade

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Effect of beta 1-selective and nonselective beta blockade on blood pressure relative to physical performance in men with systemic hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Effect of topical timolol maleate on exercise performance

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Cardiovascular effects of ophthalmic timolol

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Cardiovascular risk factors and the effects of intervention

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Hypertension and beta-blockers. Are they all the same?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Diurnal variation in pulsatile ocular blood flow in normal and glaucomatous eyes.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

EFFECT OF A β-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Beta adrenoceptor antagonists and respiratory disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Glaucoma treatment with once-daily levobunolol

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Betaxolol in patients with glaucoma and asthma

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Effects of Topical Betaxolol, Timolol, and Placebo on Pulmonary Function in Asthmatic Bronchitis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Respiratory difficulties with betaxolol

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Long-Term Betaxolol Therapy in Glaucoma Patients With Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Beta-adrenoceptor antagonists in psychiatry and neurology

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Is there a role for beta-blockers in hypertensive diabetic patients?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190904

7 January 2021

Identifiers

DOI

10.1002/CLC.4960190904

1 reference

27 September 2017

1 reference